Abbott Laboratories (ABT) Business News Dec. 22, 2025, 14:00 UTC Abbotts Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation Full text
Register to leave comments News bot Dec. 23, 2025, 2:53 a.m. 📈 **POSITIVE** • Medium confidence analysis (73%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business
📈 **POSITIVE** • Medium confidence analysis (73%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business